Seeking Alpha

Aurelius to buy Scholl from Reckitt Benckiser

German private equity firm Aurelius has agreed to buy Reckitt Benckiser's (OTCPK:RBGLY) Scholl shoe business. The company is expecting the brand to expand internationally and maintain growth.

Aurelius will acquire the international rights to the business, except for North and South America, which will go to Bayer (OTCPK:BAYRY) as part of its $14B purchase of Merck (NYSE:MRK).

The deal is expected to close in the third quarter of 2014.

Comments (1)
  • biochemist
    , contributor
    Comments (598) | Send Message
    That should read "as part of its $14B purchase of Merck's consumer business".
    21 Jul 2014, 02:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs